Takeuchi Satoshi

タケウチサトシ | Takeuchi Satoshi

Affiliation and department：
Job title： Chief doctor
Homepage URL (1)： http://kaken.nii.ac.jp/d/r/60252772.ja.html

Research field (2)： Obstetrics and gynecology , Other

Research keywords (19)： SE-9000 , 術前化学療法 , XE-2100 , シスプラチン , 透析 , CS-3000 , 骨盤灌流 , 活性炭吸着法 , 幹細胞 , EDTA-2K , Spectra , 子宮頚癌 , 動脈内化学療法 , HPC検出プログラム , 吸着療法 , 末梢血幹細胞移植 , 高用量化学療法 , ダウンステージ , 末梢血幹細胞採取

Research theme for competitive and other funds (3)：

2016 - 2019 The KANK1 pathway may be a novel therapeutic target for ovarian clear cell carcinoma
1999 - 2000 Establishment of easy detection method of peripheral blood hematologic stem cells by using hematology analyzer and its application for determination of collection volume and harvest timing.
1998 - 2000 子宮頚癌に対する活性炭吸着体外循環回路を用いた超低毒性高用量骨盤潅流化学療法

Papers (61)：

Junzo Hamanishi, Nobuhiro Takeshima, Noriyuki Katsumata, Kimio Ushijima, Tadashi Kimura, Satoshi Takeuchi, Koji Matsumoto, Kimihiko Ito, Masaki Mandai, Hidekatsu Nakai, et al. Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021. 39. 33. JCO2100334-3681
Jun Taguchi, Yasushi Shimizu, Shin Ariga, Tomohiro Goda, Yoshihito Ohhara, Rio Honma, Takuro Noguchi, Satoshi Takeuchi, Ichiro Kinoshita, Toraji Amano, et al. Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2020
Satoshi Takeuchi, Haruo Kuroboshi, Taisuke Mori, Kimihiko Ito, Eiji Kondo, Tsutomu Tabata, Yoshio Itani, Ryuji Kawaguchi, Kyosuke Takeuchi, Toshinori Soejiuma, et al. Phase 1/2 study of concurrent chemoradiotherapy with weekly irinotecan hydrochloride for advanced/recurrence uterine cancer: A multi-institutional study of Kansai Clinical Oncology Group. CHINESE JOURNAL OF CANCER RESEARCH. 2020. 32. 2. 218-227
Kosei Hasegawa, Muneaki Shimada, Satoshi Takeuchi, Hiroyuki Fujiwara, Yuichi Imai, Norihiro Iwasa, Satoru Wada, Hidetaka Eguchi, Tetsuro Oishi, Toru Sugiyama, et al. A phase 2 study of intraperitoneal carboplatin plus intravenous dose-dense paclitaxel in front-line treatment of suboptimal residual ovarian cancer. BRITISH JOURNAL OF CANCER. 2020. 122. 6. 766-770
Satoshi Takeuchi, Masahiro Kagabu, Tadahiro Shoji, Yukari Nitta, Toru Sugiyama, Junya Sato, Yusuke Nakamura. Anti-cancer immunotherapy using cancer-derived multiple epitope-peptides cocktail vaccination clinical studies in patients with refractory/persistent disease of uterine cervical cancer and ovarian cancer [phase 2]. ONCOIMMUNOLOGY. 2020. 9. 1. 1838189-1838189

ｍore...

MISC (50)：

佐藤誠也, 尾上洋樹, 黒川絵里加, 深川大輔, 佐藤千絵, 深川安寿子, 苫米地英俊, 池田真妃, 永沢崇幸, 利部正裕, et al. 岩手県におけるロボット支援下子宮体癌手術の導入. 産婦人科手術. 2019. 30. 142-142
佐藤千絵, 黒川絵里加, 深川安寿子, 苫米地英俊, 永沢崇幸, 佐藤誠也, 利部正裕, 千葉淳美, 庄子忠宏, 竹内聡, et al. LEGHを伴った子宮頸部憩室の一例. 日本産科婦人科学会雑誌. 2019. 71. 臨増. S.617-617
黒川絵里加, 佐藤千絵, 深川安寿子, 苫米地英俊, 永沢崇幸, 佐藤誠也, 利部正裕, 千葉淳美, 庄子忠宏, 竹内聡, et al. 癌性心タンポナーデを来した再発子宮体癌の一例. 日本産科婦人科学会雑誌. 2019. 71. 臨増. S.330-330
佐藤誠也, 板持広明, 深川大輔, 佐藤千絵, 菅安寿子, 苫米地英俊, 永沢崇幸, 小見英夫, 利部正裕, 千葉淳美, et al. 再発リスク因子を有するIB-II期子宮頸癌における術後補助化学療法の有用性に関する検討. 日本産科婦人科学会雑誌. 2018. 70. 2. 849-849
菅安寿子, 永沢崇幸, 佐藤誠也, 刑部光正, 石田和之, 利部正裕, 竹内聡, 板持広明, 菅井有, 杉山徹. 子宮頸部小細胞癌の一例. 日本臨床細胞学会雑誌(Web). 2017. 56. Suppl.2. 815-815

ｍore...

Professional career (1)：

Ph.D. (神戸大学)

Work history (1)：

1998 - 2000 Kobe University School of Medicine

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page